Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated the efficacy and safety of adding DA-2811 to ongoing metformin therapy in patients with Type 2 diabetes mellitus who have inadequate g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DA-2811 (DA-2811)
• metformin (metformin)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED